The medical director of NHS Blood and Transplant has warned that England’s heart and lung transplant services are being undermined by a fragmented national system, a burnt‑out workforce and inadequate accountability, in a leaked letter to NHS England and patient representatives.
Central management criticised over cancellations and capacity
Professor Derek Manas told NHS England that mismatches between waiting lists, organ availability, surgical capacity and theatre time are producing “last‑minute cancellations” and an “unpredictable utilisation of donated organs”. He criticised a system that, he said, leaves staff exhausted and offers “few consequences for poor performance”.
“leading to last‑minute cancellations [and] unpredictable utilisation of donated organs,”
The concerns come amid long‑running evidence that the UK has fallen behind peer countries in heart and lung transplantation. The NHS currently transplants about one in 10 donated lungs and one in seven donated hearts, proportions the BBC reports are roughly half those seen in some other Western nations. The number of heart and lung transplants performed annually in England has not increased in 30 years, the director added.
System design, resources and geography
NHS Blood and Transplant manages organ donation and supports surgical centres, while NHS England commissions and funds services. Professor Manas identified that division of responsibilities as a factor in what he described as a fragmented system with poor accountability.
Structural pressures cited in the letter and related reporting include:
- Lack of investment in up‑to‑date technology compared with other countries;
- Insufficient operating‑theatre availability and intensive care capacity;
- Staffing shortfalls and workforce burnout at transplant centres;
- Geographic inequities — Wales and Northern Ireland have no heart and lung transplant centres, and Scotland has only one, meaning many patients travel to England.
These problems, Professor Manas warned, reduce the NHS’s ability to make optimal use of donated organs and to scale up activity to meet demand.
Consequences for patients and the service
Last‑minute cancellations of planned transplants have direct consequences for patients on waiting lists, families and for the scarce resource of donated organs. When organs are not utilised efficiently, potential life‑saving opportunities are lost and the system’s overall performance is affected.
NHS England said it was “working hard to improve these life‑saving services”. The body commissions specialist services, but the medical director’s letter indicates deep unease about whether current national arrangements provide adequate oversight, resourcing and incentives to support centres to expand capacity and reduce cancelled procedures.
| Issue | Implication |
|---|---|
| Static transplant numbers (30 years) | Potential unmet demand; capacity not grown with need |
| Low utilisation rates (lungs & hearts) | Fewer transplants per donation compared with peers |
| Workforce burnout | Higher risk of cancellations and reduced throughput |
Policy choices will determine whether the response focuses on reorganisation of commissioning, targeted investment in theatres and intensive care, workforce recruitment and retention, or new technology to increase organ usage. Any meaningful change would also need to address how outcomes are measured and how poor performance is acted upon.
The issues raised mirror earlier reporting that the UK — once considered a leader in transplantation — has slipped relative to other nations. Recovery will require coordinated action across the national bodies that manage donation, commissioning and hospital delivery if donated organs are to be used more effectively and patients are to receive timely operations.
While the leaked letter is an internal critique, its publication invites urgent scrutiny by ministers, regulators and patient groups over whether the current national architecture for specialist services is fit for purpose, and what immediate steps can be taken to reduce cancellations and improve utilisation of donated hearts and lungs.
